Authors: Knudsen, LB Agerso, H Bjenning, C Bregenholt, S Carr, RD Godtfredsen, C Holst, JJ Huusfeldt, PO Larsen, MO Larsen, PJ Nielsen, PF Ribel, U Rolin, B Romer, J Sturis, J Wilken, M Kristensen, P

Citation: Lb. Knudsen et al., GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes:selection of NN2211 for clinical development, DRUG FUTURE, 26(7), 2001, pp. 677-685

Authors: Larsen, PJ Fledelius, C Knudsen, LB Tang-Christensen, M

Citation: Pj. Larsen et al., Systemic administration of the long-acting GLP-1 derivative NN2211 induceslasting and reversible weight loss in both normal and obese rats, DIABETES, 50(11), 2001, pp. 2530-2539

Authors: Rasch, V Knudsen, LB Wielandt, H

Citation: V. Rasch et al., Pregnancy planning and acceptance among Danish pregnant women, ACT OBST SC, 80(11), 2001, pp. 1030-1035

Authors: Knudsen, LB Nielsen, PF Huusfeldt, PO Johansen, NL Madsen, K Pedersen, FZ Thogersen, H Wilken, M Agerso, H

Citation: Lb. Knudsen et al., Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration, J MED CHEM, 43(9), 2000, pp. 1664-1669

Authors: Madsen, P Brand, CL Holst, JJ Knudsen, LB

Citation: P. Madsen et al., Advances in non-peptide glucagon receptor antagonists, CUR PHARM D, 5(9), 1999, pp. 683-691

Authors: Madsen, P Knudsen, LB Wiberg, FC Carr, RD

Citation: P. Madsen et al., Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists, J MED CHEM, 41(26), 1998, pp. 5150-5157